48,836
edits
Difference between revisions of "Renal cell carcinoma with fibromyomatous stroma"
Jump to navigation
Jump to search
Renal cell carcinoma with fibromyomatous stroma (view source)
Revision as of 20:32, 21 October 2024
, 21 Octoberno edit summary
| Line 60: | Line 60: | ||
*[[Renal neoplasms with TSC/mTOR pathway mutations|TSC/mTOR pathway mutation]].<ref name=pmid36592877/> | *[[Renal neoplasms with TSC/mTOR pathway mutations|TSC/mTOR pathway mutation]].<ref name=pmid36592877/> | ||
**A somewhat non-specific finding as [[Renal neoplasms with TSC/mTOR pathway mutations|several renal tumours (with a different morphology) have TSC/mTOR pathway mutations]]. | **A somewhat non-specific finding as [[Renal neoplasms with TSC/mTOR pathway mutations|several renal tumours (with a different morphology) have TSC/mTOR pathway mutations]]. | ||
==Sign out== | |||
===Molecular lacking=== | |||
<pre> | |||
Right Kidney, Radical Nephrectomy: | |||
- RENAL CELL CARCINOMA with clear cells, cysts and leiomyomatous stroma, see comment. | |||
-- Margin clear. | |||
-- Please see synoptic report for details. | |||
Comment: | |||
The tumour stains as follows: | |||
POSITIVE: CD10 (moderate), EMA (patchy), CK7 (diffuse), PAX8 (diffuse). | |||
NEGATIVE: CK34betaE12, CK20. | |||
The differential diagnosis includes: (1) clear cell renal cell carcinoma, (2) RCC with a mTOR pathway mutation, and (3) ELOC-mutated RCC. | |||
</pre> | |||
==See also== | ==See also== | ||